JUVENILE IDIOPATHIC ARTHRITIS
暂无分享,去创建一个
Alberto Martini | Angelo Ravelli | A. Ravelli | F. Benedetti | N. Hasson | Liza J McCann | L. R. Wedderburn
[1] C. Klersy,et al. Comparison of clinical versus ultrasound-determined synovitis in juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[2] A. Martini,et al. Phenotypic and functional characterization of switch memory B cells from patients with oligoarticular juvenile idiopathic arthritis , 2009, Arthritis research & therapy.
[3] W. Kuis,et al. Systemic JIA: new developments in the understanding of the pathophysiology and therapy. , 2009, Best practice & research. Clinical rheumatology.
[4] P. Woo,et al. An overview of genetics of paediatric rheumatic diseases. , 2009, Best practice & research. Clinical rheumatology.
[5] S. Albani,et al. Using biology of disease to understand and guide therapy of JIA. , 2009, Best practice & research. Clinical rheumatology.
[6] P. Woo. Theoretical and practical basis for early aggressive therapy in paediatric autoimmune disorders , 2009, Current opinion in rheumatology.
[7] N. Wulffraat,et al. Defective phosphorylation of interleukin-18 receptor beta causes impaired natural killer cell function in systemic-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[8] K. Minden,et al. The economic burden of juvenile idiopathic arthritis-results from the German paediatric rheumatologic database. , 2009, Clinical and experimental rheumatology.
[9] E. Haddad,et al. Predictors of early inactive disease in a juvenile idiopathic arthritis cohort: results of a Canadian multicenter, prospective inception cohort study. , 2009, Arthritis and rheumatism.
[10] Paul Pavlidis,et al. Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets. , 2009, Arthritis and rheumatism.
[11] Lukasz Itert,et al. Subtype-specific peripheral blood gene expression profiles in recent-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[12] J. Soep,et al. Anakinra for Systemic Juvenile Arthritis: The Rocky Mountain Experience , 2009, Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases.
[13] S. Kamphuis,et al. Heat shock protein 60 reactive T cells in juvenile idiopathic arthritis: what is new? , 2009, Arthritis research & therapy.
[14] Alberto Martini,et al. Development and validation of a composite disease activity score for juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[15] Seth L Masters,et al. Horror autoinflammaticus: the molecular pathophysiology of autoinflammatory disease (*). , 2009, Annual review of immunology.
[16] D. Foell,et al. The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis. , 2009, Arthritis and rheumatism.
[17] C. Wallace,et al. Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis , 2009, Arthritis research & therapy.
[18] I. Foeldvari,et al. Safety and efficacy of combination of etanercept and methotrexate compared to treatment with etanercept only in patients with juvenile idiopathic arthritis (JIA): preliminary data from the German JIA Registry , 2008, Annals of the rheumatic diseases.
[19] E. Hoppenreijs,et al. Long-term follow-up on effectiveness and safety of etanercept in juvenile idiopathic arthritis: the Dutch national register , 2008, Annals of the rheumatic diseases.
[20] A. Górska,et al. Impairment of microcirculation in juvenile idiopathic arthritis - studies by nailfold videocapillaroscopy and correlation with serum levels of sICAM and VEGF. , 2009, Folia histochemica et cytobiologica.
[21] M. Valle,et al. Magnetic resonance imaging, ultrasonography, and conventional radiography in the assessment of bone erosions in juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.
[22] Mohsen Sadatsafavi,et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. , 2008, Arthritis and rheumatism.
[23] M. Ehrenstein,et al. Defects in CTLA-4 are associated with abnormal regulatory T cell function in rheumatoid arthritis , 2008, Proceedings of the National Academy of Sciences.
[24] Bin Huang,et al. Biochemical markers of bone turnover associated with calcium supplementation in children with juvenile rheumatoid arthritis: results of a double-blind, placebo-controlled intervention trial. , 2008, Arthritis and rheumatism.
[25] A. Martini,et al. Assessing current outcomes of juvenile idiopathic arthritis: a cross-sectional study in a tertiary center sample. , 2008, Arthritis and rheumatism.
[26] A. Ramanan,et al. A case of macrophage activation syndrome successfully treated with anakinra , 2008, Nature Clinical Practice Rheumatology.
[27] D. Glass,et al. Macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis is associated with MUNC13-4 polymorphisms. , 2008, Arthritis and rheumatism.
[28] K. Minden,et al. Adalimumab with or without methotrexate in juvenile rheumatoid arthritis. , 2008, The New England journal of medicine.
[29] A. Martini,et al. Development and validation of a preliminary definition of minimal disease activity in patients with juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.
[30] A. Martini,et al. Abatacept in children with juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled withdrawal trial , 2008, The Lancet.
[31] L. Hartling,et al. Children Are Not Just Small Adults: The Urgent Need for High-Quality Trial Evidence in Children , 2008, PLoS medicine.
[32] Sampath Prahalad,et al. A comprehensive review of the genetics of juvenile idiopathic arthritis , 2008, Pediatric rheumatology online journal.
[33] Virginia Pascual,et al. How the study of children with rheumatic diseases identified interferon‐α and interleukin‐1 as novel therapeutic targets , 2008, Immunological reviews.
[34] C. Lewis,et al. Comprehensive association study of genetic variants in the IL-1 gene family in systemic juvenile idiopathic arthritis , 2008, Genes and Immunity.
[35] A. Reiff,et al. Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis. , 2008, Arthritis and rheumatism.
[36] A. Martini,et al. The pattern of response to anti-interleukin-1 treatment distinguishes two subsets of patients with systemic-onset juvenile idiopathic arthritis. , 2008, Arthritis and rheumatism.
[37] T. Kishimoto,et al. Efficacy and safety of tocilizumab in patients with systemic-onset juvenile idiopathic arthritis: a randomised, double-blind, placebo-controlled, withdrawal phase III trial , 2008, The Lancet.
[38] L. Wedderburn,et al. Interleukin-17–producing T cells are enriched in the joints of children with arthritis, but have a reciprocal relationship to regulatory T cell numbers , 2008, Arthritis and rheumatism.
[39] M. Arbogast. Sport bei Rheuma und Gelenkersatz , 2008 .
[40] M. Gattinara,et al. Focus on adverse events of tumour necrosis factor α blockade in juvenile idiopathic arthritis in an open monocentric long-term prospective study of 163 patients , 2007, Annals of the rheumatic diseases.
[41] J. Roth,et al. New insights in systemic juvenile idiopathic arthritis--from pathophysiology to treatment. , 2007, Rheumatology.
[42] J. Sibilia,et al. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France , 2007, Annals of the rheumatic diseases.
[43] R. Sundel,et al. Comparison of Vancouver and International League of Associations for rheumatology classification criteria for juvenile psoriatic arthritis. , 2008, Arthritis and rheumatism.
[44] Sherry Thornton,et al. Gene expression profiling of peripheral blood from patients with untreated new-onset systemic juvenile idiopathic arthritis reveals molecular heterogeneity that may predict macrophage activation syndrome. , 2007, Arthritis and rheumatism.
[45] V. Pascual,et al. Blood leukocyte microarrays to diagnose systemic onset juvenile idiopathic arthritis and follow the response to IL-1 blockade , 2007, The Journal of experimental medicine.
[46] A. Martini,et al. Adapted versions of the Sharp/van der Heijde score are reliable and valid for assessment of radiographic progression in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[47] A. Fischer,et al. Immunotherapy of Familial Hemophagocytic Lymphohistiocytosis With Antithymocyte Globulins: A Single-Center Retrospective Report of 38 Patients , 2007, Pediatrics.
[48] T. Lehman. The future of pediatric rheumatology: many questions remain. , 2007, Arthritis and rheumatism.
[49] C. Wouters,et al. A randomized, placebo-controlled trial of infliximab plus methotrexate for the treatment of polyarticular-course juvenile rheumatoid arthritis. , 2007, Arthritis and rheumatism.
[50] A. Martini,et al. Development and validation of a new short and simple measure of physical function for juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[51] J. Taurog. The mystery of HLA-B27: if it isn't one thing, it's another. , 2007, Arthritis and rheumatism.
[52] D. Teachey,et al. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis. , 2007, Journal of pediatric hematology/oncology.
[53] R. Cate,et al. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial. , 2007, Arthritis and rheumatism.
[54] R. Saurenmann,et al. Epidemiology of juvenile idiopathic arthritis in a multiethnic cohort: ethnicity as a risk factor. , 2007, Arthritis and rheumatism.
[55] Paul Kellam,et al. Specific gene expression profiles in systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[56] A. Zwinderman,et al. Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatment , 2007, Annals of the rheumatic diseases.
[57] A. Sette,et al. Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[58] C. Acar,et al. Valve repair for mitral insufficiency secondary to idiopathic juvenile polyarthritis. , 2007, The Journal of heart valve disease.
[59] R. Cron,et al. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. , 2007, The Journal of rheumatology.
[60] W. Thomson,et al. Positive association of SLC26A2 gene polymorphisms with susceptibility to systemic-onset juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[61] E. Neufeld,et al. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases. , 2007, The Journal of pediatrics.
[62] S. Kirschner,et al. Ergebnisse endoprothetischer Versorgung bei Patienten vor dem 50. Lebensjahr , 2007, Der Orthopäde.
[63] R. Forst,et al. Indikationen und Alternativen der endoprothetischen Versorgung beim jüngeren Patienten , 2007, Der Orthopäde.
[64] A. Ramanan,et al. The diagnostic significance of soluble CD163 and soluble interleukin-2 receptor alpha-chain in macrophage activation syndrome and untreated new-onset systemic juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[65] E. Hoppenreijs,et al. Safety of measles, mumps and rubella vaccination in juvenile idiopathic arthritis , 2007, Annals of the rheumatic diseases.
[66] A. Hoes,et al. Safety and efficacy of meningococcal c vaccination in juvenile idiopathic arthritis. , 2007, Arthritis and rheumatism.
[67] R. Saurenmann,et al. Prevalence, risk factors, and outcome of uveitis in juvenile idiopathic arthritis: a long-term followup study. , 2007, Arthritis and rheumatism.
[68] M. Aricò,et al. HLH‐2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis , 2007, Pediatric blood & cancer.
[69] H. Hamm,et al. Early onset pauciarticular arthritis is the major risk factor for naproxen-induced pseudoporphyria in juvenile idiopathic arthritis , 2007, Arthritis research & therapy.
[70] M. Ehrenstein,et al. Anti–TNF-α therapy induces a distinct regulatory T cell population in patients with rheumatoid arthritis via TGF-β , 2007, The Journal of experimental medicine.
[71] E. Hoppenreijs,et al. Blood and synovial fluid cytokine signatures in patients with juvenile idiopathic arthritis: a cross-sectional study , 2006, Annals of the rheumatic diseases.
[72] M. Sormani,et al. Lymphoid neogenesis in juvenile idiopathic arthritis correlates with ANA positivity and plasma cells infiltration. , 2006, Rheumatology.
[73] G. Janka. Familial and acquired hemophagocytic lymphohistiocytosis. , 2007, European journal of pediatrics.
[74] R. Saurenmann,et al. Risk of new-onset uveitis in patients with juvenile idiopathic arthritis treated with anti-TNFalpha agents. , 2006, The Journal of pediatrics.
[75] D. Zurakowski,et al. Patients with juvenile psoriatic arthritis comprise two distinct populations. , 2006, Arthritis and rheumatism.
[76] M. Valle,et al. Use of the Sharp and Larsen scoring methods in the assessment of radiographic progression in juvenile idiopathic arthritis. , 2006, Arthritis and rheumatism.
[77] Yasmin,et al. Rheumatoid Arthritis Is Associated With Increased Aortic Pulse-Wave Velocity, Which Is Reduced by Anti–Tumor Necrosis Factor-&agr; Therapy , 2006, Circulation.
[78] C. Lewis,et al. Novel IL10 gene family associations with systemic juvenile idiopathic arthritis , 2006, Arthritis research & therapy.
[79] R. Saurenmann,et al. Tumour necrosis factor α inhibitors in the treatment of childhood uveitis , 2006 .
[80] Bin Huang,et al. A randomized controlled trial of calcium supplementation to increase bone mineral density in children with juvenile rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[81] R. Schneider,et al. Long-term safety and efficacy of etanercept in children with polyarticular-course juvenile rheumatoid arthritis. , 2006, Arthritis and rheumatism.
[82] S. Kamphuis,et al. Heat-shock protein 60 as a tool for novel therapeutic strategies that target the induction of regulatory T cells in human arthritis , 2006, Expert opinion on biological therapy.
[83] R. Schneider,et al. Predictors of disease course and remission in systemic juvenile idiopathic arthritis: significance of early clinical and laboratory features. , 2006, Arthritis and rheumatism.
[84] J. Bolognese,et al. Evaluation of the comparative efficacy and tolerability of rofecoxib and naproxen in children and adolescents with juvenile rheumatoid arthritis: a 12-week randomized controlled clinical trial with a 52-week open-label extension. , 2006, The Journal of rheumatology.
[85] Carol A Wallace,et al. Current management of juvenile idiopathic arthritis. , 2006, Best practice & research. Clinical rheumatology.
[86] L. Wedderburn,et al. Expression of the inflammatory chemokines CCL5, CCL3 and CXCL10 in juvenile idiopathic arthritis, and demonstration of CCL5 production by an atypical subset of CD8+ T cells , 2006, Arthritis research & therapy.
[87] H. Morbach,et al. Differential expression patterns of recombination-activating genes in individual mature B cells in juvenile idiopathic arthritis , 2006, Annals of the rheumatic diseases.
[88] N. Wulffraat,et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. , 2006, Blood.
[89] H. Michels,et al. Zertifizierte Fortbildung: Gelenkerhaltende Therapie des Ellenbogenbefalls bei der juvenilen idiopathischen Arthritis , 2006 .
[90] S. Albani,et al. T cell epitope-specific immune therapy for rheumatic diseases. , 2006, Arthritis and rheumatism.
[91] P. Babyn,et al. Radiologic investigation of rheumatic diseases. , 2007, Pediatric clinics of North America.
[92] C. Dinarello,et al. Severe imbalance of IL-18/IL-18BP in patients with secondary hemophagocytic syndrome. , 2005, Blood.
[93] Bin Huang,et al. Patterns of clinical remission in select categories of juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[94] R. Laxer,et al. Medical treatment of juvenile idiopathic arthritis. , 2005, JAMA.
[95] P. Manners,et al. Infliximab for juvenile idiopathic arthritis‐associated uveitis , 2005, Clinical & experimental ophthalmology.
[96] M. Dougados,et al. Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition. , 2005, The New England journal of medicine.
[97] A. Martini,et al. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis. , 2005, The Journal of rheumatology.
[98] D. Kastner,et al. Familial autoinflammatory diseases: genetics, pathogenesis and treatment , 2005, Current opinion in rheumatology.
[99] A. Zwinderman,et al. Development of a standardized method of assessment of radiographs and radiographic change in juvenile idiopathic arthritis: introduction of the Dijkstra composite score. , 2005, Arthritis and rheumatism.
[100] B. Dardzinski,et al. Quantitative magnetic resonance imaging of the hands and wrists of children with juvenile rheumatoid arthritis. , 2005, The Journal of rheumatology.
[101] G. Horneff,et al. Etanercept and uveitis in patients with juvenile idiopathic arthritis. , 2005, Rheumatology.
[102] A. Sette,et al. Tolerogenic immune responses to novel T-cell epitopes from heat-shock protein 60 in juvenile idiopathic arthritis , 2005, The Lancet.
[103] R. Burgos-Vargas,et al. Anti–tumor necrosis factor α blockade in the treatment of juvenile spondylarthropathy , 2005 .
[104] A. Martini,et al. Development and validation of a clinical index for assessment of long-term damage in juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[105] K. Gauvreau,et al. Coronary Artery Dilation Among Patients Presenting With Systemic-Onset Juvenile Idiopathic Arthritis , 2005, Pediatrics.
[106] T. Takken,et al. Physiologic response of the six-minute walk test in children with juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[107] F. Sallusto,et al. Coexpression of CD25 and CD27 identifies FoxP3+ regulatory T cells in inflamed synovia , 2005, The Journal of experimental medicine.
[108] Wendy Thomson,et al. Association between the PTPN22 gene and rheumatoid arthritis and juvenile idiopathic arthritis in a UK population: further support that PTPN22 is an autoimmunity gene. , 2005, Arthritis and rheumatism.
[109] V. Pascual,et al. Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade , 2005, The Journal of experimental medicine.
[110] A. Reiff,et al. Etanercept treatment in patients with refractory systemic onset juvenile rheumatoid arthritis. , 2005, The Journal of rheumatology.
[111] A. Martini,et al. Preliminary diagnostic guidelines for macrophage activation syndrome complicating systemic juvenile idiopathic arthritis. , 2005, The Journal of pediatrics.
[112] N. Ilowite,et al. Response of systemic onset juvenile rheumatoid arthritis to etanercept: is the glass half full or half empty? , 2005, The Journal of rheumatology.
[113] R. Saurenmann,et al. Leflunomide or methotrexate for juvenile rheumatoid arthritis. , 2005, The New England journal of medicine.
[114] B. Prakken,et al. Heat-shock proteins induce T-cell regulation of chronic inflammation , 2005, Nature Reviews Immunology.
[115] P Woo,et al. PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it , 2005, Annals of the rheumatic diseases.
[116] A. Martini,et al. Patients with antinuclear antibody-positive juvenile idiopathic arthritis constitute a homogeneous subgroup irrespective of the course of joint disease. , 2005, Arthritis and rheumatism.
[117] P. Woo,et al. Therapeutic efficacy of humanized recombinant anti-interleukin-6 receptor antibody in children with systemic-onset juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[118] A. Martini,et al. Inherited autoinflammatory syndromes: an expanding new group of chronic inflammatory diseases. , 2005, Clinical and experimental rheumatology.
[119] T. Egeland,et al. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[120] A. Martini,et al. Targeting the interleukin-6 receptor: a new treatment for systemic juvenile idiopathic arthritis? , 2005, Arthritis and rheumatism.
[121] Jonghyeon Kim,et al. A randomized, placebo-controlled, double-masked clinical trial of etanercept for the treatment of uveitis associated with juvenile idiopathic arthritis. , 2005, Arthritis and rheumatism.
[122] C. Wouters,et al. Macrophage activation syndrome: characteristic findings on liver biopsy illustrating the key role of activated, IFN-gamma-producing lymphocytes and IL-6- and TNF-alpha-producing macrophages. , 2005, Blood.
[123] A. Prieur,et al. A randomized, double-blind clinical trial of two doses of meloxicam compared with naproxen in children with juvenile idiopathic arthritis: short- and long-term efficacy and safety results. , 2005, Arthritis and rheumatism.
[124] V. Strand,et al. Long-term open-label preliminary study of the safety and efficacy of leflunomide in patients with polyarticular-course juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[125] A. Martini,et al. Phenotypic and functional characterisation of CCR7+ and CCR7- CD4+ memory T cells homing to the joints in juvenile idiopathic arthritis , 2005, Arthritis research & therapy.
[126] Tae-Hwan Kim,et al. Pathogenesis of ankylosing spondylitis and reactive arthritis , 1994, Current opinion in rheumatology.
[127] C. Wouters,et al. Comparison of safety, efficacy and pharmacokinetics for 3 and 6 mg/kg infliximab plus methotrexate therapy in JRA patients , 2005 .
[128] M. Rewers,et al. Antibodies against cyclic citrullinated peptide are associated with HLA-DR4 in simplex and multiplex polyarticular-onset juvenile rheumatoid arthritis. , 2005, Arthritis and rheumatism.
[129] Sampath Prahalad,et al. Familial aggregation of juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.
[130] D. Foell,et al. Proinflammatory S100 proteins in arthritis and autoimmune disease. , 2004, Arthritis and rheumatism.
[131] R. Sundel,et al. Thalidomide for severe systemic onset juvenile rheumatoid arthritis: A multicenter study. , 2004, The Journal of pediatrics.
[132] G. Firestein,et al. Prevention of cold-associated acute inflammation in familial cold autoinflammatory syndrome by interleukin-1 receptor antagonist , 2004, The Lancet.
[133] E. Giannini,et al. Preliminary criteria for clinical remission for select categories of juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.
[134] S Gary Firestein,et al. Kelley's Textbook of Rheumatology , 2004 .
[135] A. Reiff,et al. Prolonged efficacy of etanercept in refractory enthesitis-related arthritis. , 2004, The Journal of rheumatology.
[136] J. Verbsky,et al. Effective use of the recombinant interleukin 1 receptor antagonist anakinra in therapy resistant systemic onset juvenile rheumatoid arthritis. , 2004, The Journal of rheumatology.
[137] N. Sinha,et al. Assessment of left ventricular systolic and diastolic function in juvenile rheumatoid arthritis. , 2004, Journal of postgraduate medicine.
[138] P. Manners,et al. Triamcinolone acetonide and hexacetonide intra-articular treatment of symmetrical joints in juvenile idiopathic arthritis: a double-blind trial. , 2004, Rheumatology.
[139] N. Wulffraat,et al. Autologous stem cell transplantation for refractory juvenile idiopathic arthritis: analysis of clinical effects, mortality, and transplant related morbidity , 2004, Annals of the rheumatic diseases.
[140] S. Bae,et al. The PRINTO /PRES international website for families of children with rheumatic diseases , 2004 .
[141] Sampath Prahalad,et al. A genome-wide scan for juvenile rheumatoid arthritis in affected sibpair families provides evidence of linkage. , 2004, Arthritis and rheumatism.
[142] Sampath Prahalad,et al. Genetics of juvenile idiopathic arthritis: an update , 2004, Current opinion in rheumatology.
[143] O. Kasapcopur,et al. Cardiopulmonary exercise testing in juvenile idiopathic arthritis. , 2004, The Journal of rheumatology.
[144] A. Martini,et al. International research networks in pediatric rheumatology: the PRINTO perspective , 2004, Current opinion in rheumatology.
[145] A. Martini,et al. Synovial expression of osteopontin correlates with angiogenesis in juvenile idiopathic arthritis. , 2004, Rheumatology.
[146] R. Saurenmann,et al. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate. , 2004, Arthritis and rheumatism.
[147] S. Sarna,et al. Growth hormone is effective in the treatment of severe growth retardation in children with juvenile chronic arthritis. Double blind placebo-controlled followup study. , 2004, The Journal of rheumatology.
[148] H. Oda,et al. Increased interleukin-18 expression in bone marrow of a patient with systemic juvenile idiopathic arthritis and unrecognized macrophage-activation syndrome. , 2004, Arthritis and rheumatism.
[149] D. Glass,et al. Juvenile rheumatoid arthritis affected sibpairs: extent of clinical phenotype concordance. , 2004, Arthritis and rheumatism.
[150] W. Kuis,et al. CD4+CD25bright Regulatory T Cells Actively Regulate Inflammation in the Joints of Patients with the Remitting Form of Juvenile Idiopathic Arthritis , 2004, The Journal of Immunology.
[151] E. Zeggini,et al. A functional promoter haplotype of macrophage migration inhibitory factor is linked and associated with juvenile idiopathic arthritis. , 2004, Arthritis and rheumatism.
[152] A Ravelli,et al. Toward an understanding of the long-term outcome of juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.
[153] R. Shamir,et al. Assessment of osteoporosis by quantitative ultrasound versus dual energy X-ray absorptiometry in children with chronic rheumatic diseases. , 2004, The Journal of rheumatology.
[154] Elizabeta Nemeth,et al. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. , 2004, The Journal of clinical investigation.
[155] I. Foeldvari,et al. The German etanercept registry for treatment of juvenile idiopathic arthritis , 2004, Annals of the rheumatic diseases.
[156] W. Kuis,et al. Safety of anti-TNFalpha therapy in children with juvenile idiopathic arthritis. , 2004, Clinical and experimental rheumatology.
[157] D. Foell,et al. Monitoring neutrophil activation in juvenile rheumatoid arthritis by S100A12 serum concentrations. , 2004, Arthritis and rheumatism.
[158] S. Kamphuis,et al. Tuberculosis in a nine-year-old girl treated with infliximab for systemic juvenile idiopathic arthritis. , 2004, Rheumatology.
[159] A. Grom. Natural killer cell dysfunction: A common pathway in systemic-onset juvenile rheumatoid arthritis, macrophage activation syndrome, and hemophagocytic lymphohistiocytosis? , 2004, Arthritis and rheumatism.
[160] M. Suarez‐Almazor,et al. International League of Associations for Rheumatology: International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001 , 2004 .
[161] R. Colbert. The immunobiology of HLA-B27: variations on a theme. , 2004, Current molecular medicine.
[162] D. Foell,et al. Methotrexate treatment in juvenile idiopathic arthritis: when is the right time to stop? , 2004, Annals of the rheumatic diseases.
[163] A. Bakkaloğlu,et al. Mitral and aortic insufficiency in polyarticular juvenile rheumatoid arthritis , 1994, Pediatric Cardiology.
[164] R. Petty,et al. The role of subcutaneous administration of methotrexate in children with juvenile idiopathic arthritis who have failed oral methotrexate. , 2004, The Journal of rheumatology.
[165] R. Misra,et al. Juvenile chronic arthritis in India: is it different from that seen in Western countries? , 2004, Rheumatology International.
[166] W. Puhl,et al. Semiarthroscopic synovectomy of the hip , 2004, International Orthopaedics.
[167] A. Martini,et al. Prognostic factors for radiographic progression, radiographic damage, and disability in juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.
[168] S. Fisher,et al. The -174G allele of the interleukin-6 gene confers susceptibility to systemic arthritis in children: a multicenter study using simplex and multiplex juvenile idiopathic arthritis families. , 2003, Arthritis and rheumatism.
[169] M. Argyropoulou,et al. Distensibility and pulse wave velocity of the thoracic aorta in patients with juvenile idiopathic arthritis: an MRI study. , 2003, Clinical and experimental rheumatology.
[170] S. Bechtold,et al. Growth hormone improves height in patients with juvenile idiopathic arthritis: 4-year data of a controlled study. , 2003, The Journal of pediatrics.
[171] Liem Jj,et al. Growth patterns in juvenile rheumatoid arthritis. , 2003 .
[172] A. Martini. Are the number of joints involved or the presence of psoriasis still useful tools to identify homogeneous disease entities in juvenile idiopathic arthritis? , 2003, The Journal of rheumatology.
[173] D. Glass,et al. Non-HLA gene polymorphisms in juvenile rheumatoid arthritis. , 2003, Clinical and experimental rheumatology.
[174] A. Martini,et al. Early predictors of outcome in juvenile idiopathic arthritis. , 2003, Clinical and experimental rheumatology.
[175] A. Martini,et al. Positive family history of psoriasis does not affect the clinical expression and course of juvenile idiopathic arthritis patients with oligoarthritis. , 2003, Arthritis and rheumatism.
[176] T. Egeland,et al. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. , 2003, Arthritis and rheumatism.
[177] J. Marini. Do bisphosphonates make children's bones better or brittle? , 2003, The New England journal of medicine.
[178] S. Kamphuis,et al. The spontaneous remission of juvenile idiopathic arthritis is characterized by CD30+ T cells directed to human heat-shock protein 60 capable of producing the regulatory cytokine interleukin-10. , 2003, Arthritis and rheumatism.
[179] Justine R. Smith,et al. Arthritis and uveitis in children. A pediatric rheumatology perspective. , 2003, American journal of ophthalmology.
[180] W. Thomson,et al. Functional and prognostic relevance of the -173 polymorphism of the macrophage migration inhibitory factor gene in systemic-onset juvenile idiopathic arthritis. , 2003, Arthritis and rheumatism.
[181] A. Zwinderman,et al. Anti-cyclic citrullinated peptide (anti-CCP) antibodies in children with juvenile idiopathic arthritis. , 2003, The Journal of rheumatology.
[182] A. Prieur,et al. Efficacy of etanercept for the treatment of juvenile idiopathic arthritis according to the onset type. , 2003, Arthritis and rheumatism.
[183] A. Zwinderman,et al. Radiologic features in juvenile idiopathic arthritis: a first step in the development of a standardized assessment method. , 2003, Arthritis and rheumatism.
[184] N. Wulffraat,et al. Reduced perforin expression in systemic juvenile idiopathic arthritis is restored by autologous stem-cell transplantation. , 2003, Rheumatology.
[185] S. Hori,et al. Control of autoimmunity by naturally arising regulatory CD4+ T cells. , 2003, Advances in immunology.
[186] P. Libby. Inflammation in atherosclerosis , 2002, Nature.
[187] T. Takken,et al. Aerobic fitness in children with juvenile idiopathic arthritis: a systematic review. , 2002, The Journal of rheumatology.
[188] P. Pelkonen,et al. The influence of heredity for psoriasis on the ILAR classification of juvenile idiopathic arthritis. , 2002, The Journal of rheumatology.
[189] N. Kamatani,et al. Association between adult-onset Still's disease and interleukin-18 gene polymorphisms , 2002, Genes and Immunity.
[190] W. Ollier,et al. Proinflammatory responses to self HLA epitopes are triggered by molecular mimicry to Epstein-Barr virus proteins in oligoarticular juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[191] P Woo,et al. Juvenile idiopathic arthritis classified by the ILAR criteria: HLA associations in UK patients. , 2002, Rheumatology.
[192] R. Burgos-Vargas,et al. A 26 week randomised, double blind, placebo controlled exploratory study of sulfasalazine in juvenile onset spondyloarthropathies , 2002, Annals of the rheumatic diseases.
[193] R. Petty,et al. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. , 2002, Arthritis and rheumatism.
[194] A. Rosenberg. Uveitis associated with childhood rheumatic diseases. , 2002, Current opinion in rheumatology.
[195] M. Cheang,et al. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. , 2002, The Journal of rheumatology.
[196] K. Miyata,et al. Highly elevated serum levels of interleukin-18 in systemic juvenile idiopathic arthritis but not in other juvenile idiopathic arthritis subtypes or in Kawasaki disease: comment on the article by Kawashima et al. , 2002, Arthritis and rheumatism.
[197] K. Minden,et al. Long-term outcome in patients with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[198] A. Ravelli. Macrophage activation syndrome. , 2002, Current opinion in rheumatology.
[199] W. Thomson,et al. Genetic epidemiology: Juvenile idiopathic arthritis genetics - What's new? What's next? , 2002, Arthritis Research.
[200] R. Burgos-Vargas. The juvenile-onset spondyloarthritides. , 2002, Rheumatic diseases clinics of North America.
[201] V. Pistoia,et al. Synovial membrane expression of matrix metalloproteinases and tissue inhibitor 1 in juvenile idiopathic arthritides. , 2002, The Journal of rheumatology.
[202] K. Oen. Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. , 2002, Best practice & research. Clinical rheumatology.
[203] P. Manners,et al. Worldwide prevalence of juvenile arthritis why does it vary so much? , 2002, The Journal of rheumatology.
[204] A. Martini,et al. Combination therapy with methotrexate and cyclosporine A in juvenile idiopathic arthritis. , 2002, Clinical and experimental rheumatology.
[205] P. Czernichow,et al. Linear growth and final height in patients with systemic juvenile idiopathic arthritis treated with longterm glucocorticoids. , 2002, The Journal of rheumatology.
[206] R. Burgos-Vargas,et al. The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology. , 2002, The Journal of rheumatology.
[207] P. Wolf,et al. Sportfähigkeit nach Schulterarthroplastik , 2002 .
[208] B. Dijkmans,et al. Severe aortic regurgitation in RF positive polyarticular JIA , 2002, Annals of the rheumatic diseases.
[209] A. Martini,et al. Macrophage migration inhibitory factor in patients with juvenile idiopathic arthritis. , 2002, Arthritis and rheumatism.
[210] P. Dungl,et al. [Knee joint synovectomy in treatment of juvenile idiopathic arthritis]. , 2002, Acta chirurgiae orthopaedicae et traumatologiae Cechoslovaca.
[211] N. Ilowite. Current treatment of juvenile rheumatoid arthritis. , 2002, Pediatrics.
[212] P. Pelkonen,et al. Construct validity of ILAR and EULAR criteria in juvenile idiopathic arthritis: a population based incidence study from the Nordic countries. International League of Associations for Rheumatology. European League Against Rheumatism. , 2001, The Journal of rheumatology.
[213] R. Merino,et al. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children. , 2001, The Journal of rheumatology.
[214] P. Woo,et al. Divergence in the degree of clonal expansions in inflammatory T cell subpopulations mirrors HLA-associated risk alleles in genetically and clinically distinct subtypes of childhood arthritis. , 2001, International immunology.
[215] G L Freeman,et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. , 2001, Arthritis and rheumatism.
[216] S. J. Lee,et al. HLA-B27 positive juvenile arthritis with cardiac involvement preceding sacroiliac joint changes , 2001, Heart.
[217] A. Prieur,et al. Reactive haemophagocytic syndrome in children with inflammatory disorders. A retrospective study of 24 patients. , 2001, Rheumatology.
[218] T. Alonzi,et al. Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. , 2001, Endocrinology.
[219] R. Häfner,et al. Evaluation of the ILAR criteria for juvenile idiopathic arthritis. , 2001, The Journal of rheumatology.
[220] S. Sawhney,et al. Macrophage activation syndrome: a potentially fatal complication of rheumatic disorders , 2001, Archives of disease in childhood.
[221] A. Reiff,et al. Safety and efficacy of high dose etanercept in treatment of juvenile rheumatoid arthritis. , 2001, The Journal of rheumatology.
[222] A. Reiff,et al. Etanercept therapy in children with treatment-resistant uveitis. , 2001, Arthritis and rheumatism.
[223] D. Glass,et al. Chemokine Receptor CCR4 on CD4+ T Cells in Juvenile Rheumatoid Arthritis Synovial Fluid Defines a Subset of Cells with Increased IL-4:IFN-γ mRNA Ratios1 , 2001, The Journal of Immunology.
[224] A. Prieur,et al. Juvenile idiopathic arthritides evaluated prospectively in a single center according to the Durban criteria. , 2001, The Journal of rheumatology.
[225] R. Petty. Growing pains: the ILAR classification of juvenile idiopathic arthritis. , 2001, The Journal of rheumatology.
[226] J. Barrett,et al. Cytokine gene polymorphisms and susceptibility to juvenile idiopathic arthritis , 2001 .
[227] G. Boivin,et al. Expression of angiogenic factors in juvenile rheumatoid arthritis: correlation with revascularization of human synovium engrafted into SCID mice. , 2001, Arthritis and rheumatism.
[228] T. Tanimoto,et al. Levels of interleukin-18 and its binding inhibitors in the blood circulation of patients with adult-onset Still's disease. , 2001, Arthritis and rheumatism.
[229] C. J. Anderson,et al. Possible role of antiidiotypes in the loss of anti-topoisomerase I antibodies: comment on the article by Kuwana et al. , 2001, Arthritis and rheumatism.
[230] F. Fantini. Classification of chronic arthritides of childhood (juvenile idiopathic arthritis): criticisms and suggestions to improve the efficacy of the Santiago-Durban criteria. , 2001, The Journal of rheumatology.
[231] P. Czernichow,et al. Linear growth in children suffering from juvenile idiopathic arthritis requiring steroid therapy: natural history and effects of growth hormone treatment on linear growth. , 2001, Journal of pediatric endocrinology & metabolism : JPEM.
[232] H. Ochs,et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3 , 2001, Nature Genetics.
[233] M. Leirisalo-Repo,et al. Magnitude of the genetic component in juvenile idiopathic arthritis , 2000, Annals of the rheumatic diseases.
[234] M. Frosch,et al. A subgroup-specific evaluation of the efficacy of intraarticular triamcinolone hexacetonide in juvenile chronic arthritis. , 2000, The Journal of rheumatology.
[235] D. Glass,et al. Twins concordant for juvenile rheumatoid arthritis. , 2000, Arthritis and rheumatism.
[236] S D Thompson,et al. Juvenile rheumatoid arthritis: linkage to HLA demonstrated by allele sharing in affected sibpairs. , 2000, Arthritis and rheumatism.
[237] M. Brandi,et al. Efficacy and safety of alendronate for the treatment of osteoporosis in diffuse connective tissue diseases in children: a prospective multicenter study. , 2000, Arthritis and rheumatism.
[238] J. Coste,et al. Long-term outcome and prognosis in oligoarticular-onset juvenile idiopathic arthritis. , 2000, Arthritis and rheumatism.
[239] A. Martini,et al. Methotrexate in juvenile idiopathic arthritis: answers and questions. , 2000, The Journal of rheumatology.
[240] S. Karademir,et al. Left Ventricular Diastolic Functions in Juvenile Rheumatoid Arthritis , 2000, Pediatric Cardiology.
[241] Andre Peeters,et al. Etanercept in children with polyarticular juvenile rheumatoid arthritis , 2000 .
[242] R. Petty,et al. Comparison of criteria for the classification of childhood arthritis. , 2000, The Journal of rheumatology.
[243] F. Riordan. Use of unlabelled and off licence drugs in children , 2000, BMJ : British Medical Journal.
[244] A. Martini,et al. Use of unlabelled and off licence drugs in children. A European paediatric rule is needed to protect children. , 2000, BMJ.
[245] Richard W. Martin,et al. A PHASE III TRIAL OF ETANERCEPT vs METHOTREXATE (MTX) IN EARLY RHEUMATOID ARTHRITIS (ENBREL ERA TRIAL) , 2000 .
[246] I. Foeldvari,et al. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology. , 2000, The Journal of rheumatology.
[247] P. Woo,et al. Selective recruitment of polarized T cells expressing CCR5 and CXCR3 to the inflamed joints of children with juvenile idiopathic arthritis. , 2000, Arthritis and rheumatism.
[248] H. Huppertz,et al. Cardiac Manifestations in Patients with HLA B27-Associated Juvenile Arthritis , 2000, Pediatric Cardiology.
[249] R. Cimaz,et al. Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. , 2000, The Journal of rheumatology.
[250] A. Schraml. Die Synovektomie des Hüftgelenkes bei juveniler chronischer Arthritis , 2000 .
[251] T. Sasazuki,et al. Identification of a genetic risk factor for systemic juvenile rheumatoid arthritis in the 5'-flanking region of the TNFalpha gene and HLA genes. , 1999, Arthritis and rheumatism.
[252] D. Glass,et al. Juvenile rheumatoid arthritis as a complex genetic trait. , 1999, Arthritis and rheumatism.
[253] L. Schanberg,et al. Prevention of leg length discrepancy in young children with pauciarticular juvenile rheumatoid arthritis by treatment with intraarticular steroids. , 1999, Arthritis and rheumatism.
[254] A. Martini,et al. Efficacy of folinic acid in reducing methotrexate toxicity in juvenile idiopathic arthritis. , 1999, Clinical and experimental rheumatology.
[255] C. Wallace,et al. On beyond methotrexate treatment of severe juvenile rheumatoid arthritis. , 1999, Clinical and experimental rheumatology.
[256] B. Andersson-Gäre. Juvenile arthritis - who gets it, where and when? : A review of current data on incidence and prevalence , 1999 .
[257] N. Wulffraat,et al. Autologous haemopoietic stem-cell transplantation in four patients with refractory juvenile chronic arthritis , 1999, The Lancet.
[258] J. Kremer,et al. A trial of etanercept, a recombinant tumor necrosis factor receptor:Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. , 1999, The New England journal of medicine.
[259] R. Ross,et al. Atherosclerosis is an inflammatory disease. , 1998, American heart journal.
[260] M. Suarez‐Almazor,et al. Revision of the proposed classification criteria for juvenile idiopathic arthritis: Durban, 1997. , 1998, The Journal of rheumatology.
[261] J S Yudkin,et al. The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. , 1998, The Journal of clinical investigation.
[262] A. Fasth,et al. Juvenile chronic arthritis in urban San José, Costa Rica: a 2 year prospective study. , 1998, The Journal of rheumatology.
[263] P. Dent,et al. Intra-articular corticosteroids in the treatment of juvenile rheumatoid arthritis. , 1998, Current opinion in rheumatology.
[264] H. Hebestreit,et al. Aerobic fitness and physical activity in patients with HLA-B27 positive juvenile spondyloarthropathy that is inactive or in remission. , 1998, The Journal of rheumatology.
[265] A. Martini,et al. Radiologic progression in patients with juvenile chronic arthritis treated with methotrexate. , 1998, The Journal of pediatrics.
[266] D. Glass,et al. Contrasting cytokine profiles in the synovium of different forms of juvenile rheumatoid arthritis and juvenile spondyloarthropathy: prominence of interleukin 4 in restricted disease. , 1998, The Journal of rheumatology.
[267] S. Padeh,et al. Intraarticular corticosteroid injection in the management of children with chronic arthritis. , 1998, Arthritis and rheumatism.
[268] R. Wolfe,et al. Severe aortic regurgitation with mechanical prosthetic valve replacement in pauciarticular juvenile rheumatoid arthritis. , 1998, The Journal of rheumatology.
[269] A. Zwinderman,et al. Sulfasalazine in the treatment of juvenile chronic arthritis: a randomized, double-blind, placebo-controlled, multicenter study. Dutch Juvenile Chronic Arthritis Study Group. , 1998, Arthritis and rheumatism.
[270] C. Wallace,et al. The use of methotrexate in childhood rheumatic diseases. , 1998, Arthritis and rheumatism.
[271] G. Kollias,et al. Interleukin 6 Is Required for the Development of Collagen-induced Arthritis , 1998, The Journal of experimental medicine.
[272] A. Martini,et al. Is systemic juvenile rheumatoid arthritis an interleukin 6 mediated disease? , 1998, The Journal of rheumatology.
[273] A. Reiff,et al. Preliminary evidence for cyclosporin A as an alternative in the treatment of recalcitrant juvenile rheumatoid arthritis and juvenile dermatomyositis. , 1997, The Journal of rheumatology.
[274] C. Rosé,et al. The effects of daily intake of folic acid on the efficacy of methotrexate therapy in children with juvenile rheumatoid arthritis. A controlled study. , 1997, The Journal of rheumatology.
[275] D. Sherry,et al. Trial of intravenous pulse cyclophosphamide and methylprednisolone in the treatment of severe systemic-onset juvenile rheumatoid arthritis. , 1997, Arthritis and rheumatism.
[276] A. Martini,et al. Cytokines in juvenile rheumatoid arthritis. , 1997, Current opinion in rheumatology.
[277] J. Jarvis,et al. Juvenile rheumatoid arthritis in African Americans. , 1997, The Journal of rheumatology.
[278] E. Tindall,et al. Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. , 1997, The New England journal of medicine.
[279] D. Felson,et al. Preliminary definition of improvement in juvenile arthritis. , 1997, Arthritis and rheumatism.
[280] A. Corti,et al. Differences in synovial fluid cytokine levels between juvenile and adult rheumatoid arthritis. , 1997, The Journal of rheumatology.
[281] R. Petty,et al. Clinical and therapeutic aspects of juvenile-onset spondyloarthropathies. , 1997, Current opinion in rheumatology.
[282] F. Ghiotto,et al. Synovial fluid T cell clones from oligoarticular juvenile arthritis patients display a prevalent Th1/Th0‐type pattern of cytokine secretion irrespective of immunophenotype , 1997, Clinical and experimental immunology.
[283] A. Corti,et al. Soluble tumour necrosis factor receptor levels reflect coagulation abnormalities in systemic juvenile chronic arthritis. , 1997, British journal of rheumatology.
[284] P. Woo,et al. Suppression of fever and the acute-phase response in a patient with juvenile chronic arthritis treated with monoclonal antibody to tumour necrosis factor-alpha (cA2). , 1997, British journal of rheumatology.
[285] M. Okuni,et al. Clinical analysis of 570 cases with juvenile rheumatoid arthritis: Results of a nationwide retrospective survey in Japan , 1997, Acta paediatrica Japonica : Overseas edition.
[286] R. Petty,et al. Rheumatoid factor positive, oligoarticular onset juvenile rheumatoid arthritis. , 1997, The Journal of rheumatology.
[287] G. Ciliberto,et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. , 1997, The Journal of clinical investigation.
[288] M. Cheang,et al. Epidemiology of chronic arthritis in childhood. , 1996, Seminars in arthritis and rheumatism.
[289] D. Witte,et al. Immunohistological characteristics of T cell infiltrates in different forms of childhood onset chronic arthritis. , 1996, The Journal of rheumatology.
[290] E. Haddad,et al. Efficacy of cyclosporine A in the treatment of macrophage activation syndrome in juvenile arthritis: report of five cases. , 1996, The Journal of pediatrics.
[291] M. Passo,et al. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis. , 1996, The Journal of pediatrics.
[292] E. Lander. The New Genomics: Global Views of Biology , 1996, Science.
[293] D. Glass,et al. Patterns of expression of tumor necrosis factor α, tumor necrosis factor β, and their receptors in synovia of patients with juvenile rheumatoid arthritis and juvenile spondylarthropathy , 1996 .
[294] R. Häfner,et al. Psoriatic arthritis in children. , 1996, Current opinion in rheumatology.
[295] P. Manners,et al. Prevalence of juvenile chronic arthritis in a population of 12-year-old children in urban Australia. , 1996, Pediatrics.
[296] M. Cazzola,et al. Defective iron supply for erythropoiesis and adequate endogenous erythropoietin production in the anemia associated with systemic-onset juvenile chronic arthritis. , 1996, Blood.
[297] L. Joosten,et al. Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice: a comparative study using anti-TNFalpha, anti-IL-1alpha/beta and IL-1Ra. , 1996 .
[298] A. Martini,et al. Macrophage activation syndrome in systemic juvenile rheumatoid arthritis successfully treated with cyclosporine. , 1996, The Journal of pediatrics.
[299] M. De Vos,et al. The evolution of spondyloarthropathies in relation to gut histology. III. Relation between gut and joint. , 1995, The Journal of rheumatology.
[300] M. Toda,et al. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. , 1995, Journal of immunology.
[301] J. Jarvis,et al. Composition and biological behaviour of immune complexes isolated from synovial fluid of patients with juvenile rheumatoid arthritis (JRA) , 1995, Clinical and experimental immunology.
[302] M. Pieper,et al. [Arthroscopic synovectomy of the knee joint in chronic juvenile arthritis]. , 1995, Zeitschrift fur Rheumatologie.
[303] J. Smallhorn,et al. Prevalence of cardiac manifestations of juvenile ankylosing spondylitis. , 1995, The American journal of cardiology.
[304] A. Reiff,et al. High dose methotrexate in the treatment of refractory juvenile rheumatoid arthritis. , 1995, Clinical and experimental rheumatology.
[305] G. Ciliberto,et al. Rational design of a receptor super‐antagonist of human interleukin‐6. , 1994, The EMBO journal.
[306] M. Cazzola,et al. Intravenous iron therapy for severe anaemia in systemic-onset juvenile chronic arthritis , 1994, The Lancet.
[307] R. Petty. Juvenile psoriatic arthritis, or juvenile arthritis with psoriasis? , 1994, Clinical and experimental rheumatology.
[308] Prieur Am,et al. Macrophage activation syndrome in rheumatic diseases in children , 1994 .
[309] B. Ansell. Juvenile psoriatic arthritis. , 1994, Bailliere's clinical rheumatology.
[310] U. Andersson,et al. Local synthesis of both macrophage and T cell cytokines by synovial fluid cells from children with juvenile rheumatoid arthritis , 1994, Clinical and experimental immunology.
[311] S. Albani,et al. Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. , 1994, The Journal of clinical investigation.
[312] T. Southwood,et al. Arthritis in Children and Adolescents , 1994 .
[313] G. Berglund,et al. Ultrasound-determined intima-media thickness and atherosclerosis. Direct and indirect validation. , 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.
[314] O. Söylemezoğlu,et al. Dilated cardiomyopathy in juvenile chronic arthritis. , 1994, Scandinavian journal of rheumatology.
[315] A. Poznanski,et al. Effects of methotrexate on radiologic progression in juvenile rheumatoid arthritis. , 1993, Arthritis and rheumatism.
[316] M. De Vos,et al. A prospective study of patients with spondyloarthropathy with special reference to HLA-B27 and to gut histology. , 1993, The Journal of rheumatology.
[317] J. Saldanha,et al. Reshaping a human antibody to inhibit the interleukin 6-dependent tumor cell growth. , 1993, Cancer Research.
[318] D. Sherry,et al. Preliminary report of higher dose methotrexate treatment in juvenile rheumatoid arthritis. , 1992, The Journal of rheumatology.
[319] R. Petty,et al. SEA syndrome revisited: a longterm followup of children with a syndrome of seronegative enthesopathy and arthropathy. , 1992, The Journal of rheumatology.
[320] W. van Eden,et al. Two monoclonal antibodies generated against human hsp60 show reactivity with synovial membranes of patients with juvenile chronic arthritis , 1992, The Journal of experimental medicine.
[321] E. Protas,et al. Exercise response in children with and without juvenile rheumatoid arthritis: a case-comparison study. , 1992, Physical therapy.
[322] B. Heimkes,et al. [Results of late synovectomy of the hip in juvenile chronic arthritis]. , 1992, Zeitschrift fur Rheumatologie.
[323] J. Cassidy,et al. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. , 1992, The New England journal of medicine.
[324] C. Wallace,et al. Dismantling the pyramid. , 1992, The Journal of rheumatology. Supplement.
[325] E. Giannini,et al. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study. , 1992, The Journal of rheumatology.
[326] M. Ferraz,et al. Symptomatic cardiac involvement in juvenile rheumatoid arthritis. , 1992, International journal of cardiology.
[327] A. Martini,et al. Correlation of serum interleukin-6 levels with joint involvement and thrombocytosis in systemic juvenile rheumatoid arthritis. , 1991, Arthritis and rheumatism.
[328] L. Sawyer,et al. Ibuprofen suspension in the treatment of juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. , 1990, The Journal of pediatrics.
[329] J. Heyd,et al. Early occurrence of aortic valve regurgitation in a youth with systemic-onset juvenile rheumatoid arthritis. , 1990, The American journal of medicine.
[330] R. Petty,et al. Psoriatic arthritis in children. , 1989, Arthritis and rheumatism.
[331] M. Bond,et al. Detection and monitoring of asymptomatic atherosclerosis in clinical trials. , 1989, The American journal of medicine.
[332] Nelson Am,et al. The frequency of juvenile arthritis. , 1988 .
[333] L. E. Clemens,et al. A crossover study of naproxen, diclofenac and tolmetin in seronegative juvenile chronic arthritis. , 1988, Clinical and experimental rheumatology.
[334] J. Cassidy,et al. The frequency of juvenile arthritis. , 1988, The Journal of rheumatology.
[335] L. D'Orsogna,et al. Aortic valve insufficiency and coronary artery narrowing in a child with polyarticular juvenile rheumatoid arthritis. , 1988, The Journal of rheumatology.
[336] B. Ansell,et al. Juvenile chronic arthritis. , 1986, Scandinavian journal of rheumatology. Supplement.
[337] M. Hall,et al. Aortic incompetence in pauciarticular juvenile chronic arthritis. , 1986, Archives of disease in childhood.
[338] E. Schned,et al. Epidemiology of juvenile arthritis in Rochester, Minnesota. , 1985, Arthritis and rheumatism.
[339] al-Hussaini Mk,et al. Cardiac tamponade in systemic juvenile rheumatoid arthritis requiring emergency pericardiectomy. , 1984 .
[340] B. Ansell,et al. The management of chronic arthritis of children. , 1983, The Journal of bone and joint surgery. British volume.
[341] W. O'Fallon,et al. The epidemiology of juvenile arthritis in Rochester, Minnesota 1960-1979. , 1983, Arthritis and rheumatism.
[342] L. E. Clemens,et al. HLA studies in IgM rheumatoid-factor-positive arthritis of childhood. , 1983, Annals of the rheumatic diseases.
[343] F. Waldman,et al. Severe aortic insufficiency in juvenile chronic arthritis. , 1983, The American journal of medicine.
[344] G. Björkhem,et al. CARDIAC INVOLVEMENT IN JUVENILE RHEUMATOID ARTHRITIS , 1983, Acta paediatrica Scandinavica.
[345] L. Lidgren,et al. Synovectomy of the hip in juvenile chronic arthritis. , 1982, The Journal of bone and joint surgery. British volume.
[346] R. Petty,et al. Textbook of pediatric rheumatology , 1982 .
[347] B. Cohlan,et al. Pericarditis and cardiac tamponade in juvenile rheumatoid arthritis. , 1981, Pediatrics.
[348] B. Ansell,et al. Aortic regurgitation in seropositive juvenile arthritis. , 1981, Annals of the rheumatic diseases.
[349] A. Larsen,et al. Radiographic Evaluation of Rheumatoid Arthritis and Related Conditions by Standard Reference Films , 1977, Acta radiologica: diagnosis.
[350] J. French,et al. Myocarditis in juvenile rheumatoid arthritis. , 1977, American journal of diseases of children.
[351] N. Gschwend,et al. Die operative Behandlung der chronischen Polyarthritis , 1977 .
[352] J. Dequeker,et al. Arthritis and heart lesions. A study of 25 cases with pericarditis or valvular lesions associated to inflammatory joint disease. , 1976, Acta cardiologica.
[353] O. Steinbrocker,et al. Therapeutic criteria in rheumatoid arthritis. , 1949, Journal of the American Medical Association.
[354] G. Still. On a form of chronic joint disease in children , 1941, Archives of disease in childhood.